Integrative Omics Analysis Reveals Soluble Cadherin-3 as a Survival Predictor and an Early Monitoring Marker of EGFR Tyrosine Kinase Inhibitor Therapy in Lung Cancer.
Ting-Feng HsiaoChih-Liang WangYi-Cheng WuHsiang-Pu FengYen-Chuan ChiuHao-Yu LinKo-Jiunn LiuGee-Chen ChangKun-Yi ChienChia-Jung YuPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
We provide useful marker candidates for drug resistance studies. sCDH3 is a survival predictor and real-time indicator of treatment efficacy in patients with ADC treated with EGFR-TKIs.